Supplementary data: New Brunswick

This page provides data visualizations related to the priorities for Canada’s cancer system.

Download the data tables and technical appendix for all indicators.

Priority 1 Action 1: Help people to stop smoking or not start in the first place and live healthier lives

Topic: Keeping people smoke-free
Title of image: Percentage of individuals in NB (aged ≥ 12) classified as daily or occasional smokers
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS).
  • Individuals who did not respond to the required CCHS questions regarding smoking status were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

NB: 13% in 2020, and 12.3% in 2021. Canada: 12.9% in 2020, and 11.8% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males in NB (aged ≥ 18) classified as daily or occasional smokers, by household income quintile
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Quintile 1: 24.5% in 2019, and 20.8% in 2021. Quintile 2: 26.4% in 2019, and 11.9% in 2021. Quintile 3: 9.6% in 2019, and 12.6% in 2021. Quintile 4: 14.3% in 2019, and 17.7% in 2021. Quintile 5: 21.4% in 2019, and 7% in 2021.Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of females in NB (aged ≥ 18) classified as daily or occasional smokers, by income quintile
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Quintile 1: 21.2% in 2019, and 17.9% in 2021. Quintile 2: 18.3% in 2019, and 11.4% in 2021. Quintile 3: 12.6% in 2019, and 17.3% in 2021. Quintile 4: 14.3% in 2019, and 8.8% in 2021. Quintile 5: 11.3% in 2019, and 9.4% in 2021.

Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in NB (aged ≥ 18) classified as overweight or obese
Caveats/limitations:

  • Individuals who did not respond to the required CCHS questions to derive the BMI classifications were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

NB: 74.5% in 2019, and 72.7% in 2021 Canada: 65.9% in 2019, and 64.7% in 2021.

Data source: Canadian Community Health Survey

Priority 1 Action 2: Adopt proven practices known to reduce the risk of cancer

Topic: Increasing HPV vaccination
Title of image: Percentage of Grade 7 students with complete HPV series by school year and sex

Caveats/limitations: The COVID-19 pandemic may have affected service provision.

HPV Male: 67.1% in 2019-2020, and 69.4% in 2022-2023. Female: 66.3% in 2019-2020, and 73% in 2022-2023.

Data source: Provincial cancer agencies and programs

Priority 2 Action 1: Prioritize rapid access to appropriate diagnosis for those suspected of having cancer

Topic: Reducing wait for diagnosis
Title of image: Percentage of colonoscopies that were completed within target (60 days after an abnormal FIT)
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

72.9% in 2019-2020. 62.9% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of colonoscopies that were completed within target (60 days after an abnormal FIT), by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019-2020: 50 to 54 years was 75.5%. 55 to 59 years was 75.9%. 60 to 64 years was 71.8%. 65 to 69 years was 70.9%. 70 to 74 years was 72.5%. In 2021: 50 to 54 years was 71%. 55 to 59 years was 53.6%. 60 to 64 years was 65.3%. 65 to 69 years was 67.4%. 70 to 74 years was 59.3%.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of women who had final resolution (within 7 weeks when biopsy was required and within 5 weeks when biopsy was not required) after an abnormal breast screening
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Breast with biopsy: In 2018 was 71.6%. In 2019 was 66.6%. In 2020 was 68.2%. Breast without biopsy: In 2018 was 72.9%. In 2019 was 76%. In 2020 was 76.3%.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of women who had final resolution within 7 weeks when biopsy was required after an abnormal breast cancer screening test result
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
In 2018-2019: 50-54 years was 45%. 55-59 years was 40%. 60-64 years was 43%. 65-69 years was 48%. 70-74 years was 52%. In 2020: 50-54 years was 63%. 55-59 years was 70%. 60-64 years was 63%. 65-69 years was 78%. 70-74 years was 66%.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of women who had final resolution within 5 weeks when biopsy was not required after an abnormal breast cancer screening test result
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2018-2019: 50 to 54 years was 74%. 55 to 59 years was 74%. 60 to 64 years was 73%. 65 to 69 years was 75%. 70 to 74 years was 77%. In 2020: 50 to 54 years was 76%. 55 to 59 years was 79%. 60 to 64 years was 76%. 65 to 69 years was 76%. 70 to 74 years was 74%.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of individuals who had a positive follow-up colonoscopy procedure and diagnosed with colon cancer
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

4.1% in 2019-2020. 4.9% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of individuals who had a positive follow-up colonoscopy procedure and diagnosed with colon cancer, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019-2020: 4.3% for Males, and 3.7% for Females. In 2021: 4.4% for Males, and 5.7% for Females.Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Percentage of individuals who had a positive follow-up colonoscopy procedure and diagnosed with colon cancer, by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

2019-2020: 50 to 54 years is 1.7%. 55 to 59 years is 1.8%. 60 to 64 years is 5.9%. 65 to 69 years is 4.2%. 70 to 74 years is 4.9%. 2021: 50 to 54 years is 3.2%. 55 to 59 years is 2.8%. 60 to 64 years is 5.5%. 65 to 69 years is 6.4%. 70 to 74 years is 5.1%.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Proportion of stage 4 at diagnosis for lung and colorectal cancer
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

For lung cancer in 2019: Males 43.7%. Females 38.9%. For lung cancer in 2020: Males 16.6%. Female 15.7%. For colorectal cancer in 2019: Males 8.7%. Females 11%. For colorectal cancer in 2020: Males 9%. Females 10.7%.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Proportion of stage at diagnosis for lung
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Stage 1: 28.7%. Stage 2: 7.4%. Stage 3: 17.5%. Stage 4: 41.5%. Other Stage: 2.7%. Stage unknown: 2.2%. In 2020: Stage 1: 14.4%. Stage 2: 2.9%. Stage 3: 1.5%. Stage 4: 16.1%. Other Stage: 2.7%. Stage unknown: 62.4%.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Proportion of stage at diagnosis for colorectal cancer
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Stage 1: 15.8%. Stage 2: 21%. Stage 3: 16.8%. Stage 4: 9.7%. Other Stage: 0.5%. Stage unknown: 36.3%. In 2020: Stage 1: 12.5%. Stage 2: 20.1%. Stage 3: 17.4%. Stage 4: 9.9%. Other Stage: 1.1%. Stage unknown: 39%.


Data source: Provincial cancer agencies and programs

Priority 2 Action 2: Strengthen existing screening efforts and implement lung cancer screening programs across the country

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals in NB who successfully completed one FIT in the program within a 30-month period (24-month screening cycle plus 6 months grace period), by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Colorectal screening In 2018-2020, 18% for Overall (age 50-74), 16.7% in 50-54 years, 13% 55-59 years, 20.5% 60-64 years, 17.3% in 65-69 years, 24.2% in 70-74 years In 2021-2023, 20.9%for Overall (age 50-74), 20.1% in 50-54 years, 17.1% 55-59 years, 21.3% 60-64 years, 22.3% in 65-69 years, 24.3% in 70-74 years

Data source: Provincial cancer agencies and programs

Priority 3 Action 1: Set best practices and standards for care delivery and promote their adoption

Topic: Implementing multidisciplinary care
Title of image: Percentage of patients diagnosed with stage II or III rectal cancer who received pre-operative radiation therapy
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

46.1% in 2017. 50.6% in 2018. 55.6% in 2019. 48.8% in 2020.Data source: Provincial cancer agencies and programs

Priority 3 Action 2: Eliminate low-benefit practices and adopt high-value practices

Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of individuals who had at least one pap test in a 42-month time frame (Jan 1, 2020 – Jun 30, 2023) by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

9.1% in age group 18-20, 55.1% in Age group 21-69 and 4.4% in 70 Plus

Data source: Provincial cancer agencies and programs

Priority 3 Action 3: Design and implement new models of care

Topic: Expanding models of care
Title of image: Percentage of patients admitted twice or more in the last 30 days of their life to acute care hospitals with cancer diagnosis for palliative care or for whom palliative care was initiated any time during the admission
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

22.9% in 2019. 21.5% in 2020.

Data source: Provincial cancer agencies and programs

Topic: Expanding models of care
Title of image: Percentage of patients admitted twice or more in the last 30 days of their life to acute care hospitals with cancer diagnosis for palliative care or for whom palliative care was initiated any time during the admission, by health region
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Health region 1: 19.3%. Health region 2: 18.4%. Health region 3: 23.6%. Health region 4: 22.2%. Health region 5: 21%. Health region 6: 30.5%. Health region 7: 35.5%. In 2020: Health region 1: 14.7%. Health region 2: 21.1%. Health region 3: 21.8%. Health region 4: 26.3%. Health region 5: 19.0%. Health region 6: 26.1%. Health region 7: 43.5%.

Data source: Provincial cancer agencies and programs

Topic: Expanding models of care
Title of image: Percentage of patients who died of cancer, by location of death
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Hospital: 69.7%. Nursing home: 4.5%. Other: 1.3%. Other healthcare facility: 12.1%. Private home: 12.5%. In 2020: Hospital: 61.9%. Nursing home: 5.4%. Other: 1.7%. Other healthcare facility: 11.7%. Private home: 19.2%.

Data source: Provincial cancer agencies and programs

Topic: Expanding models of care
Title of image: Percentage of patients who died of cancer by health region
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Health region 1: 24.4%. Health region 2: 23.1%. Health region 3: 20.8%. Health region 4: 8.2%. Health region 5: 4.8%. Health region 6: 12%. Health region 7: 6.7%. In 2020 : Health region 1: 27.2%. Health region 2: 22.7%. Health region 3: 21.1%. Health region 4: 7.7%. Health region 5: 4.4%. Health region 6: 11.4%. Health region 7: 5.6%.

Data source: Provincial cancer agencies and programs

Priority 5 Action 2: Address the limited and unequal access to palliative and end-of-life care across Canada

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (overall) who were in or admitted to an acute care hospital 30 days prior to death across NB

Median: In 2015 was 14 days. In 2017 was 14 days. In 2019 was 14 days. 90th percentile: In 2015 48 days. In 2017 52 days. In 2019 49 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (rural/remote) who were in or admitted to an acute care hospital 30 days prior to death across NB

Median: In 2015 was 12 days. In 2017 was 12 days. In 2019 was 13 days. 90th percentile: In 2015 was 45 days. In 2017 was 46 days. In 2019 was 49 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (urban) who were in or admitted to an acute care hospital 30 days prior to death across NB

Median: In 2015 was 15 days. In 2017 was 14 days. In 2019 was 15 days. 90th percentile: In 2015 was 50 days. In 2017 was 58 days. In 2019 was 50 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Download the data tables and technical appendix for all indicators.